Xelox® delivers advanced automation for Next Generation Impactor (NGI) testing, designed to meet the evolving needs of inhalation product testing. Built on Astech’s proven automation expertise, the Xelox® range spans from modular analyst workstations to fully automated 24/7 systems - supporting consistent, high-throughput, and regulatory-compliant particle size determination.
Developed in collaboration with leading pharmaceutical manufacturers, Xelox® platforms reduce manual labour, enhance data integrity, and enable scalable automation tailored to each lab's workflow and throughput demands.
Key Benefits of the Xelox® Range:
Improved result consistency through reduced manual input
Higher throughput with increased data generation
Enhanced operator health and safety - including significant WRULD risk reduction
Contained handling of drug products, reducing operator exposure
Significantly reduced analyst time on repetitive, labour-intensive tasks
Seamless upgrade paths across the product range
Standardised testing across all Xelox® systems